Demographics and Treatment of Childhood Atopic Dermatitis International Journal of Dermatology Save Recommend Share Get Topic Alerts

TAKE-HOME MESSAGE

• In this study, the authors used the National Ambulatory Medical Care Survey to characterize trends in childhood atopic dermatitis in the United States from 1995 to 2015. Annual outpatient visits for atopic dermatitis nearly tripled over the study period and visits were more common among patients of Asian, black, or Hispanic race compared with white patients. Triamcinolone, hydroxyzine, and pimecrolimus were the most common prescriptions, and hydrocortisone, cetirizine, and Cetaphil were the most commonly utilized over-the-counter agents.

• Ambulatory visits for atopic dermatitis are increasing. Despite the advent of new nonsteroidal agents, the rate of prescription of topical steroids is also continuing to rise although the study period predates dupilumab approval.

–  Caroline K. Crabtree, MD

Abstract 

Atopic dermatitis (AD) is a chronic inflammatory skin disease that frequently starts in childhood. Worldwide, the prevalence varies widely from 0.2% to 24.6% of the pediatric population1; in the United States (U.S.), AD affects approximately 13% of children.2 Among children with AD, determining changes in visit trends and patient demographics are critical to inform decisions on healthcare resource allocation. A substantial gap exists in understanding changes in visit trends for AD affecting children in the U.S. in this decade.3This study aims to determine outpatient clinic trends, patient demographics, and medication prescribing patterns for pediatric visits for AD from 1995 to 2015 in the U.S.

International Journal of Dermatology

Childhood Atopic Dermatitis: Outpatient Visit Trends, Demographics, and Topical Agents in the United States, 1995–2015

Int. J. Dermatol 2021 Apr 12;[EPub Ahead of Print], Y Gutierrez, AJ Borba, DJ Grisafe, AW Armstrong 

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.